How much did Ipremom raise?

Ipremom raised $17.4M at Seed, announced 2 September 2026.

Carlos Simón is Co-founder & Chairman of Ipremom.

What does Ipremom do?

Ipremom operates in HealthTech and is based in Spain.

FundedStartupsDaily / HealthTech / Ipremom

Ipremom raises $17.4M

Ipremom announced a Seed round of $17.4M on 2 September 2026. The company operates in HealthTech and is based in Spain. It was founded by Carlos Simón, Co-founder & Chairman.

Raised

$17.4M

Stage

Seed

Industry

HealthTech

Country

Spain

Founder

Carlos Simón

Co-founder & Chairman, Ipremom

LinkedIn not availableipremom.com

Outreach angles

-Professor Carlos Simón, an MD and PhD, previously founded Igenomix, which transformed IVF genetics before its acquisition, and is now applying the same playbook to pregnancy care.
-His research over the past decade has focused on detecting molecular signals of pregnancy complications in maternal blood as early as the first trimester.
-The 15 million euro seed round will advance Ipremom's blood test toward commercialization, aiming to flag maternal health risks months before they typically manifest.